Current Trials

All study-related visits, tests, and drugs will be provided at no cost. In addition, reimbursement for time and travel may be provided. You do not need to be a current patient of Atlanta Allergy & Asthma to participate in a research study.

Participants Needed for Pediatric Peanut Allergy Study — Epicutaneous Peanut Immunotherapy (Patch)

Qualifications to be considered for this study:

• Children ages 4 to 7 (cannot be 8 on screening day)
• Physician-diagnosed peanut allergy or children with a well-documented medical history of Ige-mediated reaction(s) after ingestion with peanut. (Children with a history of anaphylaxis, including severe anaphylaxis to peanut will be eligible)
• Excludes: Current immunotherapy for any allergen (including environmental & insect allergy)
• Excludes: Monoclonal antibody therapy within 6 months of screening
• Excludes: Uncontrolled persistent asthma

To learn more, please contact our Marietta Research facility at (770) 592-4210, or [email protected]